Zerona
Dysport®Prescription Dysport is an injection used to temporarily improve the look of moderate to severe frown lines between the eyebrows (glabellar lines) in adults less than 65 years of age. With just one injection into each of five points between and above the eyebrows, Dysport blocks the signal from the nerve to the muscles, ultimately resulting in a reduction of muscle activity and temporarily preventing contraction of the muscles that cause frown lines. The untreated facial muscles still contract normally, allowing you to freely show facial expressions, such as smiling, in untreated areas. Matrix RF Fractional Skin ResurfacingNew laser technology from Syneron Inc. provides safe treatment in patients with darker skin, using radiofrequency energy to rejuvenate skin and tissue. Surgeons can now offer laser skin resurfacing to people with Fitzpatrick skin types IV, V and VI. The Matrix RF treatment is unique in the field of aesthetic medicine. Why? It’s not a laser and it’s not a light-based therapy. The radiofrequency energy penetrates the skin to deliver heat, which stimulates collagen production. Read more...
Juvederm® XC With LidocaineYour favorite dermal filler is now available in a “no-pain” formulation. The addition of lidocaine within Juvederm Ultra XC was shown to provide a significant improvement in patient comfort. The new formula is designed for the same basic purposes – treatment of nasolabial folds and other wrinkles – but treatment is now even easier. Read more...
Latisse®Not enough lashes? Grow them! Latisse is the first and only FDA-approved prescription treatment for hypotrichosis used to grow eyelashes, making them longer, thicker, darker. Eyelash hypotrichosis is another name for having inadequate or not enough lashes. Read more ...
Velashape Cellulite Reduction™VelaShape combines patented elos technology with vacuum and tissue manipulation to reduce cellulite and body circumference. Precisely heating of fatty tissues within the treatment area reveals a smoother, tighter figure. Read more... |




